publication date: Jan. 20, 2017

In Brief

Richard Goldberg new director of West Virginia University Cancer Institute


Richard Goldberg, a gastrointestinal cancer expert, was named the new director of the WVU Cancer Institute.

Goldberg will be coming to WVU from Ohio State University’s Wexner Medical Center, where he serves as the Klotz Family Professor of Cancer Research, the physician in chief of the James Cancer Hospital, and the associate director of the Ohio State Comprehensive Cancer Center. He also served as the acting division director of the Division of Medical Oncology.

“I am honored to come to West Virginia to lead the incredible team of clinicians and researchers at the WVU Cancer Institute,” Goldberg said in a statement. “The Institute has already made great strides in the arenas of treatment, prevention, and research, and I hope that together we can accomplish even greater advances in the future.”

Goldberg will assume the leadership role held by William Petros, who has served as interim director of the WVU Cancer Institute since May 2015.


Justin Klamerus named president of Karmanos Cancer Hospital

Justin Klamerus was appointed to president of the Barbara Ann Karmanos Cancer Hospital, the clinical operation of Karmanos Cancer Institute.

The appointment is effective immediately. Klamerus will report directly to Gerold Bepler, president and CEO of Karmanos Cancer Institute.

Klamerus assumes the role after serving as interim president since April 2016, following the departure of Margaret Dimond. He will oversee all clinical operations at Karmanos’ treatment locations in Detroit and Farmington Hills, MI. He will also continue as associate professor of oncology at Wayne State University School of Medicine.

Prior to … Continue reading Richard Goldberg new director of West Virginia University Cancer Institute

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.